(Q71721275)

English

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid

scientific article published on 01 January 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Biochemotherapy of advanced metastatic renal-cell carcinoma: results of the combination of interleukin-2, alpha-interferon, 5-fluorouracil, vinblastine, and 13-cis-retinoic acid (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Atzpodien

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H Kirchner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

S Duensing

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

E Lopez Hänninen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

A Franzke

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J Buer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Probst

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P Anton

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

H Poliwoda

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

World Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

174-177

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00184875

0 references

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic renal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal cell carcinoma: natural history and results of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal, metabolic, and hemodynamic side-effects of interleukin-2 and/or interferon alpha: evidence of a risk/benefit advantage of subcutaneous therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited Efficacy of Interferon-α and Vinblastine as Second Line Biochemotherapy Regimen in Patients with Progressive Metastatic Renal Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Study of Five-Day Continuous Infusion of Vinblastine in Patients With Metastatic Renal-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European studies of interleukin-2 in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options in renal-cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal therapy and chemotherapy of renal-cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7550391

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00184875

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7550391%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71721275&oldid=1626017619"